Establishment of a mouse IgA nephropathy model with the MBP-20-peptide fusion protein

Anatomical Record

Volumn 293, Issue 10, 2010, Pages 1729-1737

  Zhang, Lei ^a   Ye, Fei ^a   He, Yan ^a   Kong, Dan ^b   Han, Changsong ^a   Zhao, Zhijie ^a   Zhu, Jiang ^a   Meng, Hongxue ^a   Liu, Xinghan ^a   Jin, Xiaoming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

20 peptide; IgA nephropathy; IgA nephropathy model; MBP 20 peptide fusion protein; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALTOSE BINDING PROTEIN; MALTOSE BINDING PROTEIN 20 PEPTIDE; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL CELL; BAGG ALBINO MOUSE; CONTROLLED STUDY; ELECTRON MICROSCOPY; EPITHELIUM CELL; EXPERIMENTAL MODEL; GLOMERULUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECOMBINANT PLASMID; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNIZATION, PASSIVE; MALE; MALTOSE-BINDING PROTEINS; MICE; MICE, INBRED BALB C; PEPTIDES, CYCLIC; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); MUS; STAPHYLOCOCCUS AUREUS;

EID: 77957675769     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21225     Document Type: Article

References (36)

1. Endo Y, Kanbayashi H, Hara M. 1993. Experimental immunoglobulin A nephropathy induced by gram-negative bacteria. Nephron 65:196-205. (Pubitemid 23268025)
2. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley MM. 2005. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436-1444.
3. Galla JH. 2001. Molecular genetics in IgA nephropathy. Nephron 88:107-112.
4. Gesualdo L, Ricanati S, Hassan MO, Emancipator SN, Lamm ME. 1990. Enzymolysis of glomerular immune deposits in vivo with dextranase/protease ameliorates proteinuria, hematuria, and mesangial proliferation in murine experimental IgA nephropathy. J Clin Invest 86:715-722. (Pubitemid 20327358)
5. Han QF, Fan MH, Zou WZ. 1998. Bacterium coli induced IgA nephropathy model. J Beijing Med Univ 30:85.
6. Hashim OH, Shuib AS, Chua CT. 2001. Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains. Nephron 89:422-425.
7. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF. 2000. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 57:1818-1835. (Pubitemid 30252274)
8. Imai H, Nakamoto Y, Asakura K, Miki K, Yasuda T, Miura AB. 1985. Spontaneous glomerular IgA deposition in ddY mice: an animal model of IgA nephritis. Kidney Int 27:756-761. (Pubitemid 15064635)
9. Isaacs K, Miller F, Lane B. 1981. Experimental model for IgA nephropathy. Clin Immunol Immunopathol 20:419-426.
10. Iwase H, Katsumata T, Itoh A, Hiki Y, Ikuko N, Sano T, Takatani T, Kobayashi Y. 2002. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. J Nephrol 15:703-708. (Pubitemid 36040575)
11. Kokubo T, Hiki Y, Iwase H, Horii A, Tanaka A, Nishikido J, Hotta K, Kobayashi Y. 1997. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J Am Soc Nephrol 8:915-919.
12. Koyama A, Kobayashi M, Yamaguchi N, Yamagata K, Takano K, Nakajima M, Irie F, Goto M, Igarashi M, Iitsuka T. 1995. Glomerulonephritis associated with MRSA infection: a possible role of bacterial superantigen. Kidney Int 47:207-216.
13. Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, Nagata M, Yoh K, Yamagata K, Muro K, Kobayashi M, Ohtani K, Shimizu T, Shimizu T. 2004. Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy. Kidney Int 66:121-132. (Pubitemid 38870088)
14. Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC. 2000. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice. J Exp Med 191:1999-2009. (Pubitemid 30390361)
15. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN. 2001. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int 59:277-285.
16. Leung JC, Tsang AW, Chan LY, Tang SC, Lam MF, Lai KN. 2002. Size-dependent binding of IgA to HepG2, U937, and human mesangial cells. J Lab Clin Med 140:398-406. (Pubitemid 36017061)
17. Liu ZH, Li LS, Li L. 1989. Staphyloentero-toxin induced IgA nephropathy model. Chin J Nephrol 5:6.
18. Long JA, Cook WJ. 2006. IgA deposits and acute glomerulonephritis in a patient with staphylococcal infection. Am J Kidney Dis 48:851-855.
19. Miyawaki S, Muso E, Takeuchi E, Matsushima H, Shibata Y, Sasayama S, Yoshida H. 1997. Selective breeding for high serum IgA levels from noninbred ddY mice: isolation of a strain with an early onset of glomerular IgA deposition. Nephron 76:201-207. (Pubitemid 27254648)
20. Montinaro V, Gesualdo L, Schena FP. 1999. The relevance of experimental models in the pathogenetic investigation of primary IgA nephropathy. Ann Med Interne (Paris) 150:99-107. (Pubitemid 29274450)
21. Rifai A, Small PA Jr, Teague PO, Ayoub EM. 1979. Experimental IgA nephropathy. J Exp Med 150:1161-1173.
22. Sánchez-Lozada LG, Tapia E, Johnson RJ, Rodríguez-Iturbe B, Herrera-Acosta J. 2003. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation. Kidney IntSuppl(86):S9-S14. (Pubitemid 37159621)
23. Sano T, Hiki Y, Kokubo T, Iwase H, Shigematsu H, Kobayashi Y. 2002. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol Dial Transplant 17:50-56. (Pubitemid 34093009)
24. Satoskar AA, Nadasdy G, Plaza JA, Sedmak D, Shidham G, Hebert L, Nadasdy T. 2006. Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 1:1179-1186.
25. Schena FP. 1995. Immunogenetic aspects of primary IgA nephropathy. Kidney Int 48:1998-2013.
26. Scolari F. 2003. Inherited forms of IgA nephropathy. J Nephrol 16:317-320.
27. Sharmin S, Shimizu Y, Hagiwara M, Hirayama K, Koyama A. 2004. Staphylococcus aureus antigens induce IgA-type glomerulonephritis in Balb/c mice. J Nephrol 17:504-511. (Pubitemid 39302877)
28. Shimizu Y, Sakurai H, Hirayama K, Seki M, Yoh K, Yamagata K, Koyama A. 2005. Staphylococcal cell membrane antigen, a possible antigen in postmethicillin resistant Staphylococcus aureus (MRSA) infection nephritis and IgA nephropathy, exhibits high immunogenic activity that is enhanced by superantigen. J Nephrol 18:249-256. (Pubitemid 41078943)
29. Shimizu Y, Seki M, Kaneko S, Hagiwara M, Yoh K, Yamagata K, Koyama A. 2007. Patients with IgA nephropathy respond strongly through production of IgA with low avidity against Staphylococcus aureus. Contrib Nephrol 157:139-143.
30. Suzuki H, Suzuki Y, Yamanaka T, Hirose S, Nishimura H, Toei J, Horikoshi S, Tomino Y. 2005. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 16:1289-1299. (Pubitemid 41716513)
31. Tamouza H, Vende F, Tiwari M, Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC, Moura IC. 2007. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy. Contrib Nephrol 157:144-147.
32. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. 1999. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73-81. (Pubitemid 29534347)
33. Van der Boog PJ, van Kooten C, de Fijter JW, Daha MR. 2005. Role of macromolecular IgA in IgA nephropathy. Kidney Int 67:813-821.
34. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. 2004. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol 136:168-175. (Pubitemid 38437779)
35. Widstam-Attorps U, Berg U, Bohman SO, Lefvert AK. 1992. Proteinuria and renal function in relation to renal morphology. A clinicopathological study of IgA nephropathy at the time of kidney biopsy. Clin Nephrol 38:245-253.
36. Yamamoto C, Suzuki S, Kimura H, Yoshida H, Gejyo F. 2002. Experimental nephropathy induced by Haemophilus parainfluenzae antigens. Nephron 90:320-327. (Pubitemid 34195759)